Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus

Lupus

Volumn 19, Issue 1, 2010, Pages 20-26

  Hou, Y F ^a   Zhang, Y C ^a   Jiao, Y L ^a   Wang, L C ^a   Li, J F ^a   Pan, Z L ^a   Yang, Q R ^a   Sun, H S ^a   Zhao, Y R ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Genes; Killer cell immunoglobulin like receptor; Lupus; Polymorphism

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE FREQUENCY; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; FEMALE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, KIR;

EID: 74849135521     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345779     Document Type: Article

References (25)

1. Chen S., Hu D., Shi X., Shen N., Gu Y., Bao C. The relationship between Thl/Th2-type cells and disease activity in patients with systemic lupus erythematosus. Chin Med J (Eng1) 2000 ; 113: 877-880.
2. Morimoto S., Tokano Y., Kaneko H., Nozawa K., Amano H., Hashimoto H. The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, TH2- related cytokines and clinical findings. Autoimmunity 2001 ; 34: 19-25.
3. Wilson MJ, Torkar M., Haude A., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000 ; 97: 4778-4783.
4. Colonna M. Immunology: Unmasking the killer s accomplice. Nature 1998 ; 391: 642-643.
5. Yen JH, Moore BE, Nakajima T., et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001 ; 193: 1159-1167.
6. Chen AM, Liu QP, Cui XY, et al. Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2008 ; 24: 811-813.
7. Pellett F., Siannis F., Vukin I., Lee P., Urowitz MB, Gladman DD KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 2007 ; 69 (Suppl 1). 106-108.
8. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 1725.
9. Martin MP, Nelson G., Lee JH, et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002 ; 169: 2818-2822.
10. National Library of Medicine (US), National Center for Biotechnology Information, Carrington M, Norman P. The KIR gene cluster , http://www.ncbi.nlm. nih.gov/books/bookres.fcgi/mono-003/ch1d1.pdf ( 2003).
11. Luszczek W., Mańczak M., CisÅ o M., et al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 2004 ; 65: 758-766.
12. Jiao YL, Ma CY, Wang LC, et al. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol 2008 ; 28: 343-349.
13. Momot T., Koch S., Hunzelmann N., et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004 ; 50: 1561-1565.
14. Van der Slik AR, Koeleman BP, Verduijn W., Bruining GJ, Roep BO, Giphart MJ KIR in Type 1 Diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003 ; 52: 2639-2642.
15. Jones DC, Edgar RS, Ahmad T., et al. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. Genes Immun 2006 ; 7: 576-582.
16. Miyashita R., Tsuchiya N., Yabe T., et al. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis Rheum 2006 ; 54: 992-997.
17. Murata H., Matsumura R., Koyama A., et al. T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis. Arthritis Rheum 2002 ; 46: 2141-2147.
18. Lorenz HM, Griinke M., Hieronymus T., et al. In vitro apoptosis and expression of apoptosis related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune disease. Arthritis Rheum 1997 ; 40: 306-317.
19. Crispin JC, Martínez A., de Pablo P., Velasquillo C., Alcocer-Varela J. Participation of the CD69 antigen in the T cell activation process of patients with systemic lupus erythematosus. Scand J Immunol 1998 ; 48: 196-200. (Pubitemid 28366011)
20. Anand A., Dean GS, Quereshi K., Isenberg DA, Lydyard PM Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus 2002 ; 11: 493-500.
21. Waszczykowska E., Robak E., Wozniacka A., Narbutt J., Torzecka JD, Sysa-Jedrzejowska A. Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation. Mediators Inflamm 1999 ; 8: 93-100.
22. Gigante A., Amoroso D., Ferri F., et al. Systemic lupus erythematosus and renal involvement: which role of citokines expression? Eur Rev Med Pharmacol Sci 2006 ; 10: 223-228.
23. Bouzahzah F., Jung S., Craft J. CD4+ T cells from lupus-prone mice avoid antigen specific tolerance induction in vivo. J Immunol 2003 ; 170: 741-748.
24. Tsokos GC, Mitchell JP, Juang YT T cell abnormalities in human and mouse lupus: intrinsic and extrinsic. Curr Opin Rheumatol 2003 ; 15: 542-547.
25. Toloza S., Pellett F., Chandran V., Ibanez D., Urowitz M., Gladman D. Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus. Lupus 2008 ; 17: 793-798.